Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser

NCT06960785 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.

NCT NCT06960785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06960785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser
Lead sponsor
Carl Zeiss Meditec AG
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2025
Completion date
February 28, 2026
Enrollment
75 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia